NHS England is supporting a campaign launched by The Sunday Times newspaper, which aims at improving cancer care. The campaign focuses on swifter diagnosis, faster and more consistent treatment across the country and more advanced radiotherapy. National Medical Director, Professor Sir Bruce Keogh, said NHS England has ambitions to raise cancer survival to match the […]

Nine hundred cancer patients every year could benefit from three new drugs which have been added to the Cancer Drugs Fund. The drugs Albumin Bound Paclitaxel, Bevacizumab and Cabozantinib are to be used to treat pancreatic cancer, brain tumours in children and thryroid cancer respectively. Albumin Bound Paclitaxel(this document is no longer available here but […]

Five hundred women every year could benefit from a new drug which has been added to the Cancer Drugs Fund to treat advanced cervical cancer. The drug bevacizumab (Avastin) is already used in the treatment of other cancers, however this is the first time it will be available on the Cancer Drugs Fund (CDF) for […]

NHS England has released an update to the national Cancer Drugs Fund list, further increasing access for patients to an additional three new cancer drugs. The additions to the list have been made following a review of trial data from the drugs by the Chemotherapy Clinical Reference Group (CRG), one of 74 such groups which […]

NHS England on behalf of the Incident Management Team today publishes the findings of its review of cancer services at Colchester Hospital University NHS Foundation Trust. The primary aim of the immediate review was to answer the question “Are the cancer services safe?” The Review took place between the 14th November and the 9th December […]

Improving Outcomes: Strategy for Cancer was published in January 2011 with the ambition to save an additional 5000 lives a year by 2014/15 and halve the gap between England and the best in Europe for survival rates. Today (10 December) the third annual report on the progress of implementation of the strategy is published. This […]

Teams of cancer specialists and other senior clinicians have begun reviews of services for every type of cancer at Colchester Hospital University NHS Foundation Trust. The review teams, which are independent of the Trust, are being co-ordinated by an NHS England-led Incident Management Team. They are examining all 14 cancer pathways at the Trust. The […]

NHS England is to lead a team of cancer specialists to ensure the safety of cancer patients following a critical report by the Care Quality Commission (CQC) into services at Colchester Hospital University Foundation Trust (CHUFT). NHS England shares the serious concerns of the CQC’s inspectors whose report reveals failures in the way some cancer […]

Manufacturers of radiotherapy equipment who are planning innovations that may change the shape of cancer care are to pitch to NHS England, Cancer Research UK and radiotherapy experts in a dragons-den style event to show the latest products available for carrying out innovative radiotherapies. The event, which takes place on the 8th and 9th October, […]

NHS England has today sanctioned a faster, more comfortable method for giving Trastuzumab (Herceptin) to breast cancer patients. From the 24th September a new sub cutaneous (SC) form of the drug will be commissioned.  Herceptin SC will primarily be used to treat women with early breast cancer who currently get the drug with chemotherapy before […]